# US 2003/0223945 A1 · Administration of pyridinedicarboxylic acid compounds for stimulating or inducing the growth of human keratinous fibers and/or arresting their loss

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0223945 A1
- Document ID: US20030223945A1
- Status: Published application
- Kind: A1
- Application number: 10/410,402
- Filed: 2003-04-10
- Published: 2003-12-04
- Earliest claimed: 2002-04-11
- Assignees: Societe L'Oreal S.A.
- Inventors: Maria Dalko; Genevieve Loussouarn; Charles El Rawadi; Christophe Boulle; Bruno Bernard
- Web page: https://patentgrep.com/patent/US20030223945A1

## CPC

- A61K 8/4926: {having six membered rings}
- A61K 8/37: Esters of carboxylic acids
- A61K 8/494: {with more than one nitrogen as the only hetero atom}
- A61K 8/4953: {containing pyrimidine ring derivatives, e.g. minoxidil}
- A61Q 1/10: for eyes, e.g. eyeliner, mascara
- A61Q 7/00: Preparations for affecting hair growth
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The invention relates to the use in a composition for caring for human hair or eyelashes of an effective amount of a pyridinedicarboxylic acid derivative of general formula (I) or of one of its salts, 1 in which R1 and R2 represent, independently of one another, OH, OR′, —NH2, —NHR′ or —NR′R″, and R′ and R″ represent, independently of one another, a saturated or unsaturated and linear or branched C1-C18 alkyl radical or an aryl radical, this alkyl or aryl radical optionally being substituted by at least one OH, alkoxy, acyloxy, amino or alkylamino group, or R′ and R″ together represent a heterocycle, the composition being intended to induce and/or stimulate the growth of human keratinous fibers, such as the hair and eyelashes, and/or slow down their loss; the invention also relates to a cosmetic treatment intended to stimulate the growth of human keratinous fibers, such as the hair and eyelashes, and/or slow down their loss.

## Claims

### Claim 1

A regime or regimen for inducing/stimulating the growth of human keratinous fibers and/or retarding the loss and/or increasing the density thereof, comprising administering to an individual subject in need of such treatment, a thus effective amount of at least one pyridinedicarboxylic acid compound having the following structural formula (I), or salt thereof:
4
in which R1 and R2, which may be identical or different, are each OH, OR′, —NH2, —NHR′ or —NR′R″, wherein R′ and R″, which also may be identical or different, are each a saturated or unsaturated linear or branched C1-C18 alkyl radical or an aryl radical, or a substituted such alkyl or aryl radical substituted with at least one OH, alkoxy, acyloxy, amino or alkylamino substituent, or R′ and R″ may together form a heterocyclic ring member.

### Claim 2 (depends on 1)

The regime or regimen as defined by claim 1, for inducing/stimulating the growth of human head hair, eyebrows, eyelashes, beard hairs, moustache hairs or pubic hairs and/or retarding the loss and/or increasing the density thereof.

### Claim 3

A regime or regimen for inducing/stimulating the growth of human head hair and/or retarding the loss and/or increasing the density thereof, comprising topically applying onto the hair and/or scalp of an individual in need of such treatment, a thus effective amount of at least one pyridinedicarboxylic acid compound having the following structural formula (I), or salt thereof:
5
in which R1 and R2, which may be identical or different, are each OH, OR′, —NH2, —NHR′ or —NR′R″, wherein R′ and R″, which also may be identical or different, are each a saturated or unsaturated linear or branched C1-C18 alkyl radical or an aryl radical, or a substituted such alkyl or aryl radical substituted with at least one OH, alkoxy, acyloxy, amino or alkylamino substituent, or R′ and R″ may together form a heterocyclic ring member.

### Claim 4

A regime or regimen for treating androgenic alopecia, comprising administering to an individual in need of such treatment, a thus effective amount of at least one pyridinedicarboxylic acid compound having the following structural formula (I), or salt thereof:
6
in which R1 and R2, which may be identical or different, are each OH, OR′, —NH2, —NHR′ or —NR′R″, wherein R′ and R″, which also may be identical or different, are each a saturated or unsaturated linear or branched C1-C18 alkyl radical or an aryl radical, or a substituted such alkyl or aryl radical substituted with at least one OH, alkoxy, acyloxy, amino or alkylamino substituent, or R′ and R″ may together form a heterocyclic ring member.

### Claim 5

A regime or regimen for caring for and/or making up human eyelashes, comprising topically applying thereon a thus effective amount of at least one pyridinedicarboxylic acid compound having the following structural formula (I), or salt thereof:
7
in which R1 and R2, which may be identical or different, are each OH, OR′, —NH2, —NHR′ or —NR′R″, wherein R′ and R″, which also may be identical or different, are each a saturated or unsaturated linear or branched C1-C18 alkyl radical or an aryl radical, or a substituted such alkyl or aryl radical substituted with at least one OH, alkoxy, acyloxy, amino or alkylamino substituent or, R′ and R″ may together form a heterocyclic ring member.

### Claim 6 (depends on 1)

The regime or regimen as defined by claim 1, wherein formula (I), R1 and R2, which may be identical or different, are each: OH, OCH3, OCH2—CH3,
8
O—CH2—O—COCH3, NHCH2—CH2—CH3, NH—CH2—CH2OH, NH—CH2—CH2—CH2OH or NH—CH2—CH2OCH3.

### Claim 7 (depends on 1)

The regime or regimen as defined by claim 1, wherein formula (I), R1 and R2, are respectively in the 2 and 3 or 2 and 4 positions of the pyridine ring.

### Claim 8 (depends on 1)

The regime or regimen as defined by claim 1, comprising administering a salt of said at least one pyridinedicarboxylic acid compound of formula (I), selected from the group consisting of the double salt of sodium or of potassium, zinc (Zn2+), calcium (Ca2+), copper (Cu2+), iron (Fe2+), strontium (Sr2+), magnesium (Mg2+) and manganese (Mn2+) salts, triethanolamine, monoethanolamine, diethanolamine, hexadecylamine, N,N,N′,N′-tetrakis(2-hydroxypropyl)-ethylenediamine or tris(hydroxymethyl)aminomethane salts, hydroxides, carbonates and chlorides.

### Claim 9 (depends on 1)

The regime or regimen as defined by claim 1, comprising administering a thus effective amount of:
pyridine-2,4-dicarboxylic acid or its zinc or sodium salt,
pyridine-2,3-dicarboxylic acid or its zinc or sodium salt,
dimethyl pyridine-2,4-dicarboxylate,
dimethyl pyridine-2,3-dicarboxylate,
diethyl pyridine-2,4-dicarboxylate,
diethyl pyridine-2,3-dicarboxylate,
diisopropyl pyridine-2,4-dicarboxylate,
2,4-di(n-propylamido) pyridine,
di(acetyloxymethyl) pyridine-2,4-dicarboxylate,
diethyl pyridine-2,5-dicarboxylate,
dimethyl pyridine-2,5-dicarboxylate,
2,4-di(2-hydroxyethylamido)pyridine,
2,4-di(3-hydroxypropylamido)pyridine, or mixture thereof.

### Claim 10 (depends on 1)

The regime or regimen as defined by claim 1, said at least one pyridinedicarboxylic acid compound of formula (I) comprising an ester.

### Claim 11 (depends on 9)

The regime or regimen as defined by claim 9, comprising administering a thus effective amount of diethyl pyridine-2,4-dicarboxylate.

### Claim 12

A cosmetic/pharmaceutical composition of matter suited for inducing/stimulating the growth of human keratinous fibers and/or retarding the loss and/or increasing the density thereof, comprising a thus effective amount of at least one pyridinedicarboxylic acid compound having the following structural formula (I), or salt thereof:
9
in which R1 and R2, which may be identical or different, are each OH, OR′, —NH2, —NHR′ or —NR′R″, wherein R′ and R″, which also may be identical or different, are each a saturated or unsaturated linear or branched C1-C18 alkyl radical or an aryl radical, or a substituted such alkyl or aryl radical substituted with at least one OH, alkoxy, acyloxy, amino or alkylamino substituent, or R′ and R″ may together form a heterocyclic ring member, formulated into a nontoxic physiologically acceptable medium therefor.

### Claim 13

A topically applicable cosmetic/pharmaceutical composition of matter suited for inducing/stimulating the growth of human keratinous fibers and/or retarding the loss and/or increasing the density thereof, comprising a thus effective amount of at least one pyridinedicarboxylic acid compound having the following structural formula (I), or salt thereof:
10
in which R1 and R2, which may be identical or different, are each OH, OR′, —NH2, —NHR′ or —NR′R″, wherein R′ and R″, which also may be identical or different, are each a saturated or unsaturated linear or branched C1-C18 alkyl radical or an aryl radical, or a substituted such alkyl or aryl radical substituted with at least one OH, alkoxy, acyloxy, amino or alkylamino substituent, or R′ and R″ may together form a heterocyclic ring member formulated into a topically applicable, nontoxic physiologically acceptable medium therefor.

### Claim 14 (depends on 13)

The topically applicable cosmetic/pharmaceutical composition as defined by claim 13, formulated as a hair cream or lotion, shampoo, hair conditioner, or mascara.

### Claim 15 (depends on 12)

The cosmetic/pharmaceutical composition as defined by claim 12, formulated as an aqueous, alcoholic or aqueous/alcoholic solution or suspension.

### Claim 16 (depends on 12)

The cosmetic/pharmaceutical composition as defined by claim 12, further comprising at least one hydrophilic or lipophilic gelling agent or thickener, hydrophilic or lipophilic additive, preservative, antioxidant, solvent, fragrance, filler, odor absorber, electrolyte, neutralizing agent, UV blocking agent, film-forming polymer, cosmetic and pharmaceutical active principle eliciting a therapeutic effect on the skin or keratinous fibers, colorant, substance P, CGRP or bradykinin antagonist, NO-synthase inhibitor, or mixture thereof.

### Claim 17 (depends on 12)

The cosmetic/pharmaceutical composition as defined by claim 12, further comprising at least one other active agent which promotes the regrowth of human keratinous fibers and/or limits the loss thereof.

### Claim 18 (depends on 12)

The cosmetic/pharmaceutical composition as defined by claim 12, further comprising at least one:
hormone;
antibacterial agent;
calcium antagonist agent;
microorganism extract;
agent which modulates cutaneous differentiation and/or proliferation;
agent which modulates bacterial adhesion to the skin and/or mucous membranes;
agent for combating parasites;
antifungal;
antiviral agent;
steroidal or nonsteroidal anti-inflammatory agent;
anaesthetic agent;
antipruriginous agent;
keratolytic agent;
agent for combating free radicals;
antiseborrheic;
antidandruff agent;
anti-acne agent;
vasodilator;
agent which reduces hair loss;
anti-androgen agent;
steroidal or nonsteroidal inhibitor of reductases;
potassium channel agonist;
FP receptor agonist; or mixture thereof.

### Claim 19 (depends on 13)

The topically applicable cosmetic/pharmaceutical composition as defined by claim 13, further comprising at least one other active agent which promotes the regrowth of human keratinous fibers and/or which limits the loss thereof, selected from the group consisting of aminexil, minoxidil, latanoprost, travoprost, and mixtures thereof.

### Claim 20 (depends on 12)

The cosmetic/pharmaceutical composition as defined by claim 12, further comprising at least one other active agent which promotes the regrowth of human keratinous fibers and/or which limits the loss thereof, selected from the group consisting of aminexil, an FP receptor, a vasodilator, and mixtures thereof.

### Claim 21 (depends on 12)

The cosmetic/pharmaceutical composition as defined by claim 12, comprising from 10−3% to 10% by weight of said at least one pyridinedicarboxylic acid compound of formula (I), or salt thereof.

### Claim 22 (depends on 12)

The cosmetic/pharmaceutical composition as defined by claim 12, comprising from 10−2% to 5% by weight of said at least one pyridinedicarboxylic acid compound of formula (I), or salt thereof.

### Claim 23 (depends on 12)

The cosmetic/pharmaceutical composition as defined by claim 12, formulated for administration by injection.

### Claim 24 (depends on 12)

The cosmetic/pharmaceutical composition as defined by claim 12, formulated for administration by ingestion.
